Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Assets Average (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Assets Average for 4 consecutive years, with $73.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets Average changed 0.05% to $73.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $73.8 million, a 0.05% change, with the full-year FY2024 number at $85.7 million, down 10.17% from a year prior.
  • Assets Average was $73.8 million for Q3 2025 at Orchestra BioMed Holdings, up from $50.9 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $161.6 million in Q2 2022 to a low of $50.9 million in Q2 2025.
  • A 4-year average of $95.8 million and a median of $85.5 million in 2022 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: grew 28.83% in 2023, then tumbled 40.87% in 2024.
  • Orchestra BioMed Holdings' Assets Average stood at $82.1 million in 2022, then grew by 28.83% to $105.8 million in 2023, then fell by 28.4% to $75.7 million in 2024, then decreased by 2.55% to $73.8 million in 2025.
  • Per Business Quant, the three most recent readings for OBIO's Assets Average are $73.8 million (Q3 2025), $50.9 million (Q2 2025), and $67.6 million (Q1 2025).